Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02079584 · ClinicalTrials.gov registry record
Outpatient Treatment of Low-Risk Venous Thromboembolism With Target Specific Anticoagulant
A clinical trial, sponsored by Indiana University.
- Completed
- Registry status
- 83
- Enrollment target
NCT02079584 is a clinical trial that has completed, run by Indiana University. The registered enrollment target is 83 participants.
The verdict
NCT02079584 has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- 83 participants
- Enrollment target
Study Summary
The objectives of this registry are to measure the outcomes, cost, adherence pattern and experience of patients treated as outpatients with rivaroxaban after being diagnosed with blood clots in the emergency department. The investigators hypothesize that patients will have a relatively low rate of adverse events and higher adherence than has been reported historically for warfarin treatment. Patients will be scheduled for follow up care with one of Dr. Kline's Outpatient Thrombosis clinics at Methodist Hospital, Eskenazi Health Services and the Baylor University Medical Center (Dallas, TX) after diagnosis and treatment of pulmonary embolism (PE) or deep vein thrombosis (DVT).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 83 participants |
| Start Date | 2013-03 |
| Est. Completion | 2014-08-14 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02079584
The ClinicalTrials.gov registry entry for NCT02079584 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 83 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02079584 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02079584 about?
NCT02079584 is a clinical study titled "Outpatient Treatment of Low-Risk Venous Thromboembolism With Target Specific Anticoagulant". The objectives of this registry are to measure the outcomes, cost, adherence pattern and experience of patients treated as outpatients with rivaroxaban after being diagnosed with blood clots in the emergency department. The investigators hypothesize that patients will have a relatively low rate of a...
What is the current status of trial NCT02079584?
This trial is currently completed. The enrollment target is 83 participants. The study started on 2013-03. Estimated completion is 2014-08-14.
Who is sponsoring clinical trial NCT02079584?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.